Ostomy firm Trio Healthcare expands to US
Ostomy company Trio Healthcare, based in Skipton and Knutsford, has opened its first US office in Princeton, New Jersey.
The US ostomy market is valued at $1.5 billion and the country has more than 725,000 people living with a stoma.
Trio will launch its stoma bag within American markets in the first quarter of next year. The company recently secured US patent approval for its Sil2 technology, a breathable silicone material which adheres well to skin, but repels moisture, rather than absorbing it. It therefore does not disintegrate, slip, or irritate the skin – a common problem with traditional ostomy products that rely on hydrocolloid adhesives. Sil2 has also received patent approval in Japan, Canada and Australia.
Following approximately $10 million in funding from US-based SWK Holdings Corporation earlier this year, Trio has increased investment into its R&D teams, doubled its headcount, and expanded its Skipton manufacturing facilities.
Trio also launched teams in the MENA and Asia-Pacific region last April, appointing Hussain Malkawi and Christian Stegle as business directors in Dubai and Singapore respectively. The company stated it is looking for acquisitions in North America and Brazil.
Newly appointed Trio Healthcare chief executive, Chris Lane, said: “The Trio team has built a successful UK business with a global reach, and we are investing significantly in our people and infrastructure to accelerate this. The North American ostomy market is a lynchpin of these expansion plans and establishing our first office in the region will enable us to better reach the clinicians and patients we aim to support with our silicone innovations.
Jay Thompson has joined Trio as vice-president and general manager, with Nick Noble appointed as vice-president of sales and business development and Andy Marxen as clinical director. Thompson and Noble have experience in the North American healthcare and medical technology market. Thompson previously worked at global medical specialist ConvaTec, and the pair have also worked with the likes of wound care disruptor Crawford Healthcare and Acelity, as well as healthcare giant 3M.
Thompson said: “Having spent over 20 years in the healthcare market over in the States, I’m incredibly excited to join Trio to establish the company in the US. I’ve launched numerous medical devices, but this company and new technology have a special meaning to me. I have lived with Crohn’s disease for 20 years, so I’m excited to have the opportunity to bring a product to market that is a significant advancement in ostomy care and can significantly impact the quality of life for so many people.”
Noble added: “Trio is on an incredible growth journey, and it’s a privilege to join at such a pivotal time for the company. I’ve worked closely with Jay and the UK team in previous guises over the years, and the team has the experience and drive to make the business a Stateside success. The stoma market is an under-resourced field of healthcare, and we have significant opportunity here to make a real difference to the lives of thousands of ostomates across the US.”
Date published: November 9, 2021